Aspen Aerogels, Inc.
NYSE:ASPNConstruction
+$0.24 today
- Market cap
- $407.33M
- Beta
- 2.99
- P/E (TTM)
- -4.6
- EPS (TTM)
- -$1.35
Volume 1.17M
Average 1.58M
ASPN Other Income / Expenses
Net non-operating gains and losses, such as investment results, currency effects, and one-off items.
Aspen Aerogels, Inc.NYSE: ASPN
Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026
Other income / expenses remains negative
Q1 FY2026 other income / expenses was -$3.54M, compared with -$832K a year earlier. Trailing-twelve-month other income / expenses was -$338.47M.
Context
- Other income / expenses amounted to 123.9% of revenue in FY2025, up 115.1 pp from a year earlier.
- Other income / expenses increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other income / expenses holds near -$3.54M or moves back toward the trailing-twelve-month quarterly average of -$84.62M.
Sources:Income StatementText generated from reported figures; not investment advice.
Other Income / Expenses history
USD · from the income statement
- Latest · FY2025
- (335.77M) USD
- Year-over-year change
- -751.2%
| Period | Period end | Other Income / Expenses | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (335.77M) | -751.2% |
| FY2024 | 2024-12-31 | (39.45M) | -1262.9% |
| FY2023 | 2023-12-31 | 3.39M | +197.1% |
| FY2022 | 2022-12-31 | (3.49M) | -199.7% |
| FY2021 | 2021-12-31 | 3.51M | — |
Other Income / Expenses vs competitors
How ASPN compares with its peers on the latest reported figures
- Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -820.7% is the lowest of 10, against a peer median of -17.6%.
- Other income / expenses amounts to 147.0% of revenue for ASPN, versus a peer median of 3.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CN¥37.13M CNY | +11.0% | — | 8.9% | |
| LTM Mar 2026 | $20.09M USD | -17.6% | +17.9% | 9.6% | |
| LTM Mar 2026 | $4.61M USD | +258.6% | +132.7% | — | |
| FY2025 | €1.25M EUR | +101.4% | -60.4% | 4.0% | |
| LTM Feb 2026 | -$20.91M USD | -277.6% | — | 1.5% | |
| LTM Apr 2026 | -$33.94M USD | -80.1% | — | 1.1% | |
| LTM Apr 2026 | -$39.93M USD | -2.8% | — | 2.2% | |
| LTM Mar 2026 | -$58.6M USD | -109.3% | — | 1.6% | |
| LTM Mar 2026 | -$338.47M USD | -820.7% | — | 147.0% | |
| LTM Mar 2026 | -$403.58M USD | -234.2% | — | 67.9% | |
| Peer median (excluding ASPN) | — | -17.6% | +17.9% | 3.1% | |
Competitors are the stored peer set for ASPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 121.62M | 180.36M | 238.72M | 452.7M | 271.1M |
| Cost of Revenue | 111.69M | 175.39M | 181.8M | 269.8M | 225.11M |
| Gross Profit | 9.94M | 4.98M | 56.92M | 182.9M | 46M |
| Gross Margin | 8.2% | 2.8% | 23.8% | 40.4% | 17.0% |
| Research & Development | 11.44M | 16.93M | 16.36M | 18.05M | 6.3B |
| Selling, General & Admin | 39.1M | 67.29M | 89.77M | 106.8M | 40.91B |
| Operating Expenses | 50.54M | 84.22M | 106.12M | 128.36M | 97.39M |
| Depreciation & Amortization | 9.44M | 9.22M | 18.18M | 24.41M | 45.16M |
| EBITDA | (27.43M) | (68.41M) | (22.31M) | 51.46M | 5.72B |
| EBITDA Margin | -22.5% | -37.9% | -9.3% | 11.4% | 2108.3% |
| Operating Income | (40.6M) | (79.25M) | (49.2M) | 54.54M | (51.39M) |
| Operating Margin | -33.4% | -43.9% | -20.6% | 12.0% | -19.0% |
| Interest Income | 0 | 1.62M | 6.53M | 0 | 0 |
| Interest Expense | 229K | 5.11M | 5.33M | 11.96M | 6.06B |
| Other Income / Expenses | 3.51M | (3.49M) | 3.39M | (39.45M) | (335.77M) |
| Income Before Tax | (37.09M) | (82.74M) | (45.81M) | 15.09M | (387.16M) |
| Pre-Tax Margin | -30.5% | -45.9% | -19.2% | 3.3% | -142.8% |
| Income Tax Expense | 0 | 0 | 0 | 1.71M | 2.39M |
| Net Income | (37.09M) | (82.74M) | (45.81M) | 13.38M | (389.55M) |
| Net Margin | -30.5% | -45.9% | -19.2% | 3.0% | -143.7% |
| EPS (Basic) | (0.92) | (2.19) | (0.66) | 0.17 | (4.74) |
| EPS (Diluted) | (0.92) | (2.19) | (0.66) | 0.17 | (4.74) |
| Weighted Avg Shares | 30.43M | 39.36M | 69.44M | 77.54M | 82.66M |
| Weighted Avg Shares (Diluted) | 30.43M | 39.36M | 69.44M | 80.31M | 82.66M |
Aspen Aerogels, Inc.
NYSE:ASPN
Intrinsic Alpha fair value
Locked
Current Price
$4.90
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.